Moolec Science (MLEC) Revenue (2023 - 2024)

Moolec Science's (MLEC) quarterly Revenue came in at $2.6 million in Q4 2024, up 948.32% year-on-year from $252114.0 in Q1 2024, and up 69.75% quarter-over-quarter from $1.6 million in Q3 2024.

Moolec Science (MLEC) Revenue (2023 - 2024) Analysis & Trends

Moolec Science has disclosed Revenue across 2 years of filings, most recently posting $2.6 million for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Moolec Science 6.98 Bn 6.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.64 Mn
Sep 30, 2024 1.56 Mn
Mar 31, 2024 2.11 Mn
Dec 31, 2023 252,114.00
Sep 30, 2023 1.74 Mn